|
1
|
Yue Y, Liu J and He C: RNA
N6-methyladenosine methylation in post-transcriptional
gene expression regulation. Genes Dev. 29:1343–1355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zaccara S, Ries RJ and Jaffrey SR:
Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell
Biol. 20:608–624. 2013. View Article : Google Scholar
|
|
3
|
Batista PJ: The RNA modification
N6-methyladenosine and its implications in human
disease. Genomics Proteomics Bioinformatics. 15:154–163. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han
D, Ma H, Weng X, Cgen K, Shi H and He C: N(6)-methyladenosine
modulates messenger RNA translation efficiency. Cell.
161:1388–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu
PJ, Liu C and He C: YTHDF3 facilitates translation and decay of
N6-methyladenosine-modified RNA. Cell Res. 27:315–328. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi H, Wei J and He C: Where, when, and
how: Context-dependent functions of RNA methylation writers,
readers, and erasers. Mol Cell. 74:640–650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang S, Sun C, Li J, Zhang E, Ma Z, Xu W,
Li H, Qiu M, Xu Y, Xia W, et al: Roles of RNA methylation by means
of N6-methyladenosine (m6A) in human cancers. Cancer Lett.
408:112–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan Q, Liu PY, Haase J, Bell JL,
Hüttelmaier S and Liu T: The critical role of RNA m6A methylation
in cancer. Cancer Res. 79:1285–1292. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Visvanathan A, Patil V, Arora A, Hegde AS,
Arivazhagan A, Santosh V and Somasundaram K: Essential role of
METTL3-mediated m6A modification in glioma stem-like cells
maintenance and radioresistance. Oncogene. 37:522–533. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen M, Wei L, Law CT, Tsang FH, Shen J,
Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al: RNA
N6-methyladenosine methyltransferase-like 3 promotes liver cancer
progression through YTHDF2-dependent posttranscriptional silencing
of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R,
Wang YY and Zhe H: FTO regulates the chemo-radiotherapy resistance
of cervical squamous cell carcinoma (CSCC) by targeting β-catenin
through mRNA demethylation. Mol Carcinog. 57:590–597. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Zhao BS, Zhou A, Lin K, Zheng S,
Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, et al: m(6)A demethylase
ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by
sustaining FOXM1 expression and cell proliferation program. Cancer
Cell. 31:591–606.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lyons K, Le LC, Pham YT, Borron C, Park
JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, et al: Gastric
cancer: Epidemiology, biology, and prevention: A mini review. Eur J
Cancer Prev. 28:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Zheng D, Wang F, Xu Y, Yu H and
Zhang H: Expression of demethylase genes, FTO and ALKBH1, is
associated with prognosis of gastric cancer. Dig Dis Sci.
64:1503–1513. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T, Yang S, Sui J, Xu SY, Cheng YP,
Shen B, Zhang Y, Zhang XM, Yin LH, Pu YP and Liang GY: Dysregulated
N6-methyladenosine methylation writer METTL3 contributes to the
proliferation and migration of gastric cancer. J Cell Physiol.
235:548–562. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katoh M: Canonical and non-canonical WNT
signaling in cancer stem cells and their niches: Cellular
heterogeneity, omics reprogramming, targeted therapy and tumor
plasticity (Review). Int J Onco. 51:1357–1369. 2017. View Article : Google Scholar
|
|
18
|
Aggarwal A, Leong SH, Lee C, Kon O and Tan
P: Wavelet transformations of tumor expression profiles reveals a
pervasive genome-wide imprinting of aneuploidy on the cancer
transcriptome. Cancer Res. 65:186–194. 2005.PubMed/NCBI
|
|
19
|
Xu QW, Zhao W, Wang Y, Sartor MA, Han DM,
Deng J, Ponnala R, Yang JY, Zhang QY, Liao GQ, et al: An integrated
genome-wide approach to discover tumor-specific antigens as
potential immunologic and clinical targets in cancer. Cancer Res.
72:6351–6361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S
and He Y: Low expression of SOCS-1 and SOCS-3 is a poor prognostic
indicator for gastric cancer patients. J Cancer Res Clin Oncol.
141:443–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inagaki-Ohara K, Kondo T, Ito M and
Yoshimura A: SOCS, inflammation, and cancer. JAKSTAT.
2:e240532013.PubMed/NCBI
|
|
22
|
Sutherland KD, Lindeman GJ, Choong DY,
Wittlin S, Brentzell L, Phillips W, Campbell IG and Visvader JE:
Differential hypermethylation of SOCS genes in ovarian and breast
carcinomas. Oncogene. 23:7726–7733. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Slattery ML, Lundgreen A, Hines LM,
Torres-Mejia G, Wolff RK, Stern MC and John EM: Genetic variation
in the JAK/STAT/SOCS signaling pathway influences breast
cancer-specific mortality through interaction with cigarette
smoking and use of aspirin/NSAIDs, the breast cancer health
disparities study. Breast Cancer Res Treat. 147:145–158. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoefer J, Kern J, Ofer P, Eder IE, Schäfer
G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, et
al: SOCS2 correlates with malignancy and exerts growth-promoting
effects in prostate cancer. Endocr Relat Cancer. 21:175–187. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Das R, Gregory PA, Fernandes RC, Denis I,
Wang Q, Townley SL, Zhao SG, Hanson AR, Pickering MA, Armstrong HK,
et al: MicroRNA-194 promotes prostate cancer metastasis by
inhibiting SOCS2. Cancer Res. 77:1021–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vitali C, Bassani C, Chiodoni C, Fellini
E, Guarnotta C, Miotti S, Sangaletti S, Fuligni F, De Cecco L,
Piccaluga PP, et al: SOCS2 controls proliferation and stemness of
hematopoietic cells under stress conditions and its deregulation
marks unfavorable acute leukemias. Cancer Res. 75:2387–2399. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Gong AY, Ma S, Chen X,
Strauss-Soukup JK and Chen XM: Delivery of parasite Cdg7_Flc_0990
RNA transcript into intestinal epithelial cells during
cryptosporidium parvum infection suppresses host cell gene
transcription through epigenetic mechanisms. Cell Microbiol.
19:e127602017. View Article : Google Scholar
|
|
28
|
Ming Z, Gong AY, Wang Y, Zhang XT, Li M,
Mathy NW, Strauss-Soukup JK and Chen XM: Involvement of
cryptosporidium parvum Cdg7_FLc_1000 RNA in the attenuation of
intestinal epithelial cell migration via trans-suppression of host
cell SMPD3. J Infect Dis. 217:122–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Gong AY, Ma S, Chen X, Li Y, Su
CJ, Norall D, Chen J, Strauss-Soukup JK and Chen XM: Delivery of
parasite RNA transcripts into infected epithelial cells during
cryptosporidium infection and its potential impact on host gene
transcription. J Infect Dis. 215:636–643. 2017.PubMed/NCBI
|
|
30
|
Durham GA, Williams JJL, Nasim MT and
Palmer TM: Targeting SOCS proteins to control JAK-STAT signalling
in disease. Trends Pharmacol Sci. 40:298–308. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stark GR and Darnell JE Jr: The JAK-STAT
pathway at twenty. Immunity. 36:503–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng X, Su R, Weng H, Huang H, Li Z and
Chen J: RNA N6-methyladenosine modification in cancers: Current
status and perspectives. Cell Res. 28:507–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, Sun
G, Lu Z, Huang Y, Yang CG, et al: m(6)A RNA methylation regulates
the self-renewal and tumorigenesis of glioblastoma stem cells. Cell
Rep. 18:2622–2634. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vu LP, Pickering BF, Cheng Y, Zaccara S,
Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M, et al:
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid
differentiation of normal hematopoietic and leukemia cells. Nat
Med. 23:1369–1376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lino CA, Harper JC, Carney JP and Timlin
JA: Delivering CRISPR: A review of the challenges and approaches.
Drug Deliv. 25:1234–1257. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dimitriou ID, Clemenza L, Scotter AJ, Chen
G, Guerra FM and Rottapel R: Putting out the fire: Coordinated
suppression of the innate and adaptive immune systems by SOCS1 and
SOCS3 proteins. Immunol Rev. 224:265–283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Palmer DC and Restifo NP: Suppressors of
cytokine signaling (SOCS) in T cell differentiation, maturation,
and function. Trends Immunol. 30:592–602. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Letellier E and Haan S: SOCS2:
Physiological and pathological functions. Front Biosci (Elite Ed).
8:189–204. 2016.PubMed/NCBI
|
|
39
|
Khanna P, Chua PJ, Wong BSE, Yin C, Thike
AA, Wan WK, Tan PH and Baeg GH: GRAM domain-containing protein 1B
(GRAMD1B), a novel component of the JAK/STAT signaling pathway,
functions in gastric carcinogenesis. Oncotarget. 8:115370–115383.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kong D and Wang Y: Knockdown of lncRNA
HULC inhibits proliferation, migration, invasion, and promotes
apoptosis by sponging miR-122 in osteosarcoma. J Cell Biochem.
119:1050–1061. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lui AJ, Geanes ES, Ogony J, Behbod F,
Marquess J, Valdez K, Jewell W, Tawfik O and Lewis-Wambi J: IFITM1
suppression blocks proliferation and invasion of aromatase
inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated
induction of p21. Cancer Lett. 399:29–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cho KH, Jeong KJ, Shin SC, Kang J, Park CG
and Lee HY: STAT3 mediates TGF-β1-induced TWIST1 expression and
prostate cancer invasion. Cancer Lett. 336:167–173. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Twyman-Saint Victor C, Rech AJ, Maity A,
Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi
PM, et al: Radiation and dual checkpoint blockade activate
non-redundant immune mechanisms in cancer. Nature. 520:373–377.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Trengove MC and Ward AC: SOCS proteins in
development and disease. Am J Clin Exp Immunol. 2:1–29.
2013.PubMed/NCBI
|
|
45
|
Zhou X, Xia Y, Li L and Zhang G: MiR-101
inhibits cell growth and tumorigenesis of helicobacter pylori
related gastric cancer by repression of SOCS2. Cancer Biol Ther.
16:160–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang C, Zhang M, Ge S, Huang W, Lin X,
Gao J, Gong J and Shen L: Reduced m6A modification predicts
malignant phenotypes and augmented Wnt/PI3K-Akt signaling in
gastric cancer. Cancer Med. 8:4766–4781. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin S, Liu J, Jiang W, Wang P, Sun C, Wang
X, Chen Y and Wang H: METTL3 promotes the proliferation and
mobility of gastric cancer cells. Open Med (Wars). 14:25–31. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
He H, Wu W, Sun Z and Chai L: MiR-4429
prevented gastric cancer progression through targeting METTL3 to
inhibit m6A-caused stabilization of SEC62. Biochem Biophys Res
Commun. 517:581–587. 2019. View Article : Google Scholar : PubMed/NCBI
|
